Company news
ZYUS Life Sciences Corporation news in 2026
ZYUS Life Sciences Corporation's news releases, calls and decks from 2026, newest first.
ZYUS Life Sciences Announces Closing of Second Tranche of Non-Brokered Unit Offering Private Placement
November 6, 2026
ZYUS Life Sciences Announces Closing of First Tranche of Non-Brokered Unit Offering Private Placement
October 21, 2026
ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Cancer
October 1, 2026
ZYUS Life Sciences Corporation Announces Planned Release Date for Phase 2a Clinical Trial Results, Annual General Meeting Results and Change in Audit Committee Chair
September 24, 2026
ZYUS Life Sciences Corporation Provides General Business Update and Announces Changes in Executive Leadership
September 15, 2026
ZYUS Life Sciences Corporation Provides Liquidity and Working Capital Update and Announces Reinstatement to Trading
September 9, 2026
ZYUS Life Sciences Corporation Announces Completion of Secured Loan Financing
August 31, 2026
ZYUS Life Sciences Corporation Announces Closing of Ninth Tranche of Secured Loan Financing
August 18, 2026
ZYUS Life Sciences Corporation Announces Closing of Eighth Tranche of Secured Loan Financing and Amendment to Unsecured Promissory Note
August 13, 2026
ZYUS Life Sciences Corporation Announces Closing of Seventh Tranche of Secured Loan Financing
July 29, 2026
ZYUS Life Sciences Corporation Announces Revocation of Failure-to-File Cease Trade Order
July 21, 2026
ZYUS Life Sciences Corporation Announces Closing of Sixth Tranche of Secured Loan Financing
July 21, 2026
ZYUS Announces Database Lock for its Phase 2a UTOPIA-1 Trial, CFO Transition and Continuous Disclosure Update
July 19, 2026
ZYUS Life Sciences Corporation Announces Closing of Fifth Tranche of Secured Loan Financing
July 2, 2026
ZYUS Life Sciences Corporation Announces Closing of Fourth Tranche of Secured Loan Financing
June 24, 2026
ZYUS Life Sciences Corporation Announces Closing of Third Tranche of Secured Loan Financing
June 17, 2026
ZYUS Life Sciences Announces Strategic Realignment to Prioritize Drug Development
June 11, 2026
ZYUS Life Sciences Corporation Announces Closing of Second Tranche of Secured Loan Financing and Provides an Update on its Annual Filings and Q1 2026 Financial Statement
May 28, 2026
ZYUS Life Sciences Corporation Announces Closing of First Tranche of Secured Loan Financing and Provides an Update on its Annual Filings
May 20, 2026
ZYUS Announces Cease Trade Order
May 6, 2026
ZYUS Life Sciences Expands U.S. Patent Portfolio with Second Pain Management Patent
May 5, 2026
ZYUS Announces Delay in Its Annual Filings
April 30, 2026
ZYUS Life Sciences Announces Completion of the Final Study Visit by the Last Patient in Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug
April 16, 2026
ZYUS Life Sciences Provides an Update on Its Unit Offering
April 10, 2026
ZYUS Life Sciences Announces Closing of Debt Financing
March 5, 2026
ZYUS Life Sciences Announces Cancellation of LIFE Offering and Launch of Private Placement
February 24, 2026
ZYUS Life Sciences Announces Filing of Amended and Restated LIFE Offering Document
February 9, 2026
ZYUS Life Sciences Announces Amendment to Subleases and Promissory Note Agreement
February 4, 2026
ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units
January 12, 2026
ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug
January 8, 2026
Decks in 2026
- Investor Presentation (October 2026)
Investor deck · 26 slides · Oct 9, 2026